The Los Angeles Post
U.S. World Business Lifestyle
Today: March 16, 2025
Today: March 16, 2025

Biden administration’s negotiated price cuts for 10 common prescription drugs likely to save Medicare billions, beginning in 2026

Strong industry resistance, but companies negotiated

Despite their vocal opposition and their ongoing public relations campaign that has attacked this process, all affected U.S. drugmakers decided to engage in the price negotiations.

The daunting alternatives, including paying a penalty that could run as high as 95% of their U.S. pharmaceutical product sales, and a requirement to pull their drugs from the Medicare and Medicaid markets, proved to be strong incentives.

However, the manufacturers of medications have been fighting the measure in court. And despite several losses, this battle will likely continue for the foreseeable future, with uncertain outcomes.

Why US drug prices are so high

Americans pay substantially more for prescription drugs compared with people who live in countries with similar economies. For example, per capita pharmaceutical spending in the U.S. amounted to $1,432 compared to $1,042 in Germany and $766 in France in 2022.

The reasons for this disparity are multilayered and include the overall complexity of the U.S. health care system and the lack of transparency in the drug supply chain. Of course, many other countries also directly set prices for drugs or use their monopoly over health services to drive down costs.

Drug costs impose a big burden on Americans. People who are 65 and older are particularly affected, with 1 in 5 not taking all of their medications as prescribed due to high costs.

Older adult customer standing at a pharmacy checkout stand, with pharmacist explaining something.

The first 10 drugs selected for negotiated pricing can be picked up at a pharmacy.

Maskot/Getty Images

Weighing the prospects of price negotiations

In my view, the government’s efforts are a step in the right direction. The potential for real savings for Americans 65 and older will undoubtedly grow as more drug prices are negotiated.

Yet, some real concerns remain.

Even if the negotiated lower prices survive the industry’s legal challenges, it’s possible that future Republican administrations won’t embrace this policy, as Republicans have historically opposed price negotiations for Medicare.

The true effect for patients with Medicare will likely be much smaller than it appears. That’s because the Medicare program and patients often already receive discounts on many of these drugs. These discounts will now be eliminated.

In addition, the pharmaceutical industry has a history of skillfully exploiting loopholes that may further limit the financial impact. Manufacturers have already told shareholders that they expect limited impacts on their profits.

It’s also too soon to tell if this is going to be a win for all Americans. It’s possible that Americans who aren’t covered by Medicare may actually see prices go up, even on these same drugs. Working Americans could thus wind up shouldering ever larger burdens to deliver this support for older adults.

This article includes passages that were included in a previous article published on Aug. 30, 2023.

The Conversation

Simon F. Haeder does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.


Source: The Conversation

Related

Business|Europe|Finance|Stock Markets

Porsche SE says it is not considering sale of Volkswagen shares

Business|Economy|Finance|MidEast|Political

US weighing in on Lebanon's next central bank chief, sources say

Asia|Business|Science|Technology

China's Baidu launches two new AI models as industry competition heats up

Business|Crime|Technology|US

Cybersecurity officials warn against potentially costly Medusa ransomware attacks

Local

Lifestyle|Local

Holi celebrations in Los Angeles this weekend

Local|Lifestyle|News|WrittenByLAPost

Los Angeles Marathon to take place Sunday

Local|News

California allocates $300M for enhanced local road safety measures

Local|News

Rain expected to hit Southern California by Tuesday

Share This

Popular

Business|Europe|Finance|Stock Markets

Porsche SE says it is not considering sale of Volkswagen shares

Porsche SE says it is not considering sale of Volkswagen shares
Business|Economy|Finance|MidEast|Political

US weighing in on Lebanon's next central bank chief, sources say

US weighing in on Lebanon's next central bank chief, sources say
Asia|Business|Science|Technology

China's Baidu launches two new AI models as industry competition heats up

China's Baidu launches two new AI models as industry competition heats up
Business|Crime|Technology|US

Cybersecurity officials warn against potentially costly Medusa ransomware attacks

Cybersecurity officials warn against potentially costly Medusa ransomware attacks

Health

Europe|Health|Political|World

Pope Francis signals intention to remain in post with sign-off on three-year reform plan

Pope Francis signals intention to remain in post with sign-off on three-year reform plan
Health|Lifestyle

Your boozy nightcap is disrupting your sleep. Try these tips instead

Your boozy nightcap is disrupting your sleep. Try these tips instead
Health|MidEast|World

Nine killed in Israeli attack in northern Gaza, officials say, in deadliest strike since ceasefire began

Nine killed in Israeli attack in northern Gaza, officials say, in deadliest strike since ceasefire began
Health|Political|US

A father of a trans man voted for Trump. Now he fears an order targeting gender-affirming care will upend his son’s treatment

A father of a trans man voted for Trump. Now he fears an order targeting gender-affirming care will upend his son’s treatment

Access this article for free.

Already have an account? Sign In